#47 in Health among publishers in Google Discover in Brazil over the last 30 days.

Track in D2TR
BrazilLast 30 days
#47in Health
28DTRSDTRS, its score in Health
⁦<0.1%⁩share of visibility
#47in Health

Market share

Last 60 days
Impressions per day47.1Kin the last 14 days

Slice of the market

⁦<0.1%⁩of all Google Discover visibility in Brazil
  • Eli Lilly⁦<0.1%⁩
  • Rest of the top 1036.8%
  • Everyone else63.2%

Top publications

Lilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss

Impressions47.1K
HealthIn D2TR

Publications by impressions

ImpressionsPubsShare of total
Over 5M0%0%
1M to 5M0%0%
100K to 1M0%0%
10K to 100K100%100%
Under 10K0%0%

100% of its publications bring 100% of its impressions.

Where it ranks

By category

Impressions, last 14 days
HealthNew in the top 50#47
Other categories47.1K

What it publishes

Content formats

  • News100.0%

Who it competes with

Trends they share

Times they met
Eli Lilly's Foundayo pill reduces sleep apnea severity in late-stage trialagainst ⁨CNBC⁩ and ⁨Scientific American⁩2 times
Every trend it competes on, in D2TR

About ⁨Eli Lilly⁩

Main category
Health
In D2TR data
since May 2026
Knowledge Graph ID
/g/11nc84s010

Google profile

Open profile
0total followers
Last 90 days

Its records

Best rank
outside the top 50 current 30 days
In the top 10
in no period on record
The numbers behind the rankSign up to open the full impressions history, feed positions, authors and every article of ⁦investor.lilly.com⁩.
Sign up

Rank and share come from the D2TR publisher ranking and are rebuilt every 7 days. Impressions are shown for the last 14 days. Estimates, not Google data. D2TR is not affiliated with Google or with ⁨Eli Lilly⁩.